Friday, July 10, 2026

pharma · Myelodysplastic Syndromes (MDS) · Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML)

Taiho Pharma Canada

News and analysis for Taiho Pharma Canada on NovaPharmaNews — regulatory, clinical, and market coverage.

2010 Winston Park Drive, Suite 503, Oakville, Ontario L6H 5R7, CA HQ
2017 Founded
13 Employees
EMA registrant Type
Company details
Status
Public
HQ
2010 Winston Park Drive, Suite 503, Oakville, Ontario L6H 5R7, CA
Founded
2017
Employees
13
Programs
16
Drugs
30
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Taiho Pharma Canada — regulatory, clinical, and market coverage.

News and analysis for Taiho Pharma Canada on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Taiho Pharma Canada yet.

Back to company overview →